Evaluation of clinical course, histopathological and treatment characteristics of patients with Kaposi's sarcoma

dc.authorid0000-0002-5040-6901
dc.authorid0000-0002-3457-1958
dc.contributor.authorPolat, Asude Kara
dc.contributor.authorKaraali, Muge Gore
dc.contributor.authorAksu, Ayse Esra Koku
dc.contributor.authorEblebici, Cem
dc.contributor.authorGürel, Mehmet Salih
dc.date.accessioned2025-05-10T19:59:13Z
dc.date.issued2018
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground and Design: Kaposi's sarcoma (KS) is an anjoproliferative disease of vascular endothelium associated with human herpes virus-8 (HHV-8). The purpose of this study was to evaluate the clinical course, histopathological and treatment characteristics in patients with KS. Materials and Methods: A retrospective study was conducted on 77 patients with KS who attended the Dermatology Outpatient Clinic in the Istanbul Training and Research Hospital between April 2008 and December 2016. The clinical course, histopathological and treatment characteristics were evaluated from the hospital records. Results: The mean age of the patients was 67.4 +/- 13.8 years. 67.5% of patients were male and 32.5% were female. Five patients (6.5%) had oral mucosal involvement. Human immunodeficiency virus positivity was detected in 4 patients (5.2%). HHV-8, CD-31 and CD-34 positivity were detected in 94.0%, 98.0% and 84.2% of patients, respectively. Three patients (3.9%) had secondary malignancy (1 patient had lymphoma, 1 had thyroid carcinoma and 1 had bladder carcinoma). The most commonly used treatments were cryotherapy (26.3%) as monotherapy, and excision and cryotherapy (14.8%) as combination therapy. Conclusion: Clinical and histopathological features are important in establishing the diagnosis of KS. In our study, the rate of unresponsiveness to treatment observed in follow-up was low and progression was rare. Screening and follow-up of the secondary malignancies that may accompany KS should be carried out with caution.
dc.identifier.doi10.4274/turkderm.89982
dc.identifier.endpage136
dc.identifier.issn1019-214X
dc.identifier.issn1308-6294
dc.identifier.issue4
dc.identifier.scopus2-s2.0-85072266803
dc.identifier.scopusqualityN/A
dc.identifier.startpage131
dc.identifier.trdizinid295952
dc.identifier.urihttps://doi.org/10.4274/turkderm.89982
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/295952
dc.identifier.urihttps://hdl.handle.net/20.500.14730/13790
dc.identifier.volume52
dc.identifier.wosWOS:000457043200004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherDeri Zuhrevi Hastaliklar Dernegi
dc.relation.ispartofTurkderm-Turkish Archives of Dermatology and Venerology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectKaposi's sarcoma
dc.subjecthistopathology
dc.subjectHHV-8
dc.subjectimmunohistochemistry
dc.subjectsecondary malignancy
dc.subjecttreatment
dc.titleEvaluation of clinical course, histopathological and treatment characteristics of patients with Kaposi's sarcoma
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
13790.pdf
Boyut:
1.34 MB
Biçim:
Adobe Portable Document Format